Stay updated on VTX958 vs Placebo in Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the VTX958 vs Placebo in Psoriatic Arthritis Clinical Trial page.

Latest updates to the VTX958 vs Placebo in Psoriatic Arthritis Clinical Trial page
- Check3 days agoChange DetectedA site-wide notice announces updates about NIH websites and says both “Super Intelligence” and “Artificial Intelligence” may appear during the transition.SummaryDifference1%

- Check10 days agoChange DetectedThe footer revision label advances from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check31 days agoChange DetectedRemoved the 403 Forbidden block, allowing the page to render its content instead of an access-denied screen. This change affects the visibility of the study details to users seeking information about the trial.SummaryDifference0.5%

- Check38 days agoChange DetectedThe study record page now shows a 403 error instead of the expected content, indicating restricted access to the NCT05715125 details.SummaryDifference17%

- Check59 days agoChange DetectedPage revision updated from v3.6.5 to v3.6.6, indicating a new version of the page was deployed. This update appears to be a backend or metadata refresh rather than a substantive change to the study details.SummaryDifference0.0%

Stay in the know with updates to VTX958 vs Placebo in Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VTX958 vs Placebo in Psoriatic Arthritis Clinical Trial page.